Showing results (161-170 of 214) with videos related to
Sort By:
Pageof 22
European Journal of Medicinal Chemistry|October 22, 2013
Novel polyamine analogues: from substrates towards potential inhibitors of monoamine oxidasesEmanuela Bonaiuto, Andrea Milelli, Giorgio Cozza, et al.Free Radical Biology & Medicine|December 21, 2019
Lack of glutathione peroxidase-8 in the ER impacts on lipid composition of HeLa cells microsomal membranesValentina Bosello Travain, Giovanni Miotto, Ana-Marija Vučković, et al.Cancer Letters|November 5, 2011
Nanoencapsulated anti-CK2 small molecule drug or siRNA specifically targets malignant cancer but not benign cellsJaneen H Trembley, Gretchen M Unger, Vicci L Korman, et al.Journal of Medicinal Chemistry|November 30, 2004
Optimization of protein kinase CK2 inhibitors derived from 4,5,6,7-tetrabromobenzimidazoleMario A Pagano, Mariola Andrzejewska, Maria Ruzzene, et al.Biopolymers|October 1, 2003
Conformational constraints of tyrosine in protein tyrosine kinase substrates: Information about preferred bioactive side-chain orientationPaolo Ruzza, Andrea Calderan, Arianna Donella-Deana, et al.Biochimica Et Biophysica Acta|October 9, 2008
Glycolytic enzyme expression and pyruvate kinase activity in cultured fibroblasts from type 1 diabetic patients with and without nephropathyElisabetta Iori, Renato Millioni, Lucia Puricelli, et al.Biochimica Et Biophysica Acta|March 5, 2013
Protein disulfide isomerase and glutathione are alternative substrates in the one Cys catalytic cycle of glutathione peroxidase 7Valentina Bosello-Travain, Marcus Conrad, Giorgio Cozza, et al.The Journal of Clinical Investigation|January 15, 2005
Chronic lymphocytic leukemia B cells contain anomalous Lyn tyrosine kinase, a putative contribution to defective apoptosisAntonella Contri, Anna Maria Brunati, Livio Trentin, et al.Cancer Letters|March 22, 2016
New potential peptide therapeutics perturbing CK1δ/α-tubulin interactionMarc Krüger, Hubert Kalbacher, Panagiotis L Kastritis, et al.Molecular and Cellular Biochemistry|December 13, 2005
Development and exploitation of CK2 inhibitorsStefania Sarno, Maria Ruzzene, Pietrogiulio Frascella, et al.Pageof 22